Watch: GOP Senator Says Trump’s Tariffs Could Mean Safer Drugs

Extra Extra has grouped 3 reports on this story from 3 news outlets across the political spectrum. By political lean, that breaks down as 2 center and 1 right-leaning sources.

Its coverage-diversity score of 58 out of 100 means the story is being reported across multiple parts of the spectrum, though the volume leans toward one side. Notably, no left-leaning outlet in our index has picked the story up yet — a left-side blind spot that often signals a topic resonating more with conservative audiences.

On reliability, 2 of the 3 rated outlets carry a high or mostly-factual reliability rating (A or B) and 1 outlet fall into our mixed or lower-reliability tier (C or D). Ratings are drawn from independent assessments and are meant to help you weigh each report, not to tell you which to trust.

This story has been covered over the span of about 2 days, making it a longer-running thread rather than a single news flash.

Below, the same story is laid out side by side as left, center, and right outlets reported it. Read across the columns and watch what changes: the headline emphasis, which facts lead, the adjectives, and what each side leaves out. The story itself rarely changes — the framing almost always does.